
Dexcom reports strong Q2 growth and raises full-year guidance on G7 adoption and international expansion
Dexcom (DXCM) posted robust Q2 2026 results with 13.1% revenue growth and nearly 50% operating income increase, driven by adoption of its G7 system and international market expansion. The company also advanced its 'Road to 100' initiative to broaden ...

